1,835
Views
38
CrossRef citations to date
0
Altmetric
Reviews

Association between polypharmacy and dementia – A systematic review and metaanalysis

&
Pages 932-941 | Received 11 Jan 2018, Accepted 15 Apr 2018, Published online: 10 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Lauren Swan, N Frances Horgan, Chie Wei Fan, Austin Warters & Maria O’Sullivan. (2022) Residential Area Socioeconomic Deprivation is Associated with Physical Dependency and Polypharmacy in Community-Dwelling Older Adults: An Analysis of Health Administrative Data in Ireland. Journal of Multidisciplinary Healthcare 15, pages 1955-1963.
Read now
Eleanor Curnow, Robert Rush, Donald Maciver, Sylwia Górska & Kirsty Forsyth. (2021) Exploring the needs of people with dementia living at home reported by people with dementia and informal caregivers: a systematic review and Meta-analysis. Aging & Mental Health 25:3, pages 397-407.
Read now

Articles from other publishers (36)

Taro Kusama, Kenji Takeuchi, Sakura Kiuchi, Jun Aida & Ken Osaka. (2023) Poor oral health and dementia risk under time‐varying confounding: A cohort study based on marginal structural models. Journal of the American Geriatrics Society.
Crossref
Raaj S. Mehta, Bharati Kochar, Zhen Zhou, Jonathan C. Broder, Paget Chung, Keming Yang, Jessica Lockery, Michelle Fravel, Joanne Ryan, Suzanne Mahady, Suzanne G. Orchard, John J. McNeil, Anne Murray, Robyn L. Woods, Michael E. Ernst & Andrew T. Chan. (2023) Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study. Gastroenterology 165:3, pages 564-572.e1.
Crossref
Jure Mur, Riccardo E. Marioni, Tom C. Russ, Graciela Muniz‐Terrera & Simon R. Cox. (2023) Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy. British Journal of Clinical Pharmacology 89:7, pages 2224-2235.
Crossref
Jennifer Rollo, John Crawford & John Hardy. (2023) A dynamical systems approach for multiscale synthesis of Alzheimer’s pathogenesis. Neuron 111:14, pages 2126-2139.
Crossref
Deborah Inyang, Tasneem Saumtally, Chinelo Nonyerem Nnadi, Sharmila Devi & Po-Wah So. (2023) A Systematic Review of the Effects of Capsaicin on Alzheimer’s Disease. International Journal of Molecular Sciences 24:12, pages 10176.
Crossref
Yoshitaka Saito, Satoru Oishi, Takeya Takizawa, Hiroyuki Muraoka, Yuki Yoshimura, Itsuki Hashimoto, Ryutaro Suzuki, Tsuyoshi Ono & Ken Inada. (2023) Analysis of Concomitant Medications Prescribed with Antipsychotics to Patients with Dementia. Dementia and Geriatric Cognitive Disorders, pages 1-10.
Crossref
Laura Ashley, Claire Surr, Rachael Kelley, Mollie Price, Alys Wyn Griffiths, Nicole R. Fowler, Dana E. Giza, Richard D. Neal, Charlene Martin, Jane B. Hopkinson, Anita O’Donovan, William Dale, Bogda Koczwara, Katie Spencer & Lynda Wyld. (2022) Cancer care for people with dementia: Literature overview and recommendations for practice and research. CA: A Cancer Journal for Clinicians 73:3, pages 320-338.
Crossref
Ana Lopez-de-Andres, Rodrigo Jimenez-Garcia, Jose J. Zamorano-Leon, Ricardo Omaña-Palanco, David Carabantes-Alarcon, Valentin Hernández-Barrera, Javier De Miguel-Diez & Natividad Cuadrado-Corrales. (2023) Prevalence of Dementia among Patients Hospitalized with Type 2 Diabetes Mellitus in Spain, 2011–2020: Sex-Related Disparities and Impact of the COVID-19 Pandemic. International Journal of Environmental Research and Public Health 20:6, pages 4923.
Crossref
Xiaoqiang Xiao, Shunju Xiang, Qingya Xu, Jieying Li, Jun Xiao & Yang Si. (2023) Comorbidity among inpatients with dementia: a preliminary cross-sectional study in West China. Aging Clinical and Experimental Research 35:3, pages 659-667.
Crossref
Ho Jin Cho, Jungmi Chae, Sang‐Heon Yoon & Dong‐Sook Kim. (2022) Factors related to polypharmacy and hyper‐polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea. Clinical and Translational Science 16:2, pages 193-205.
Crossref
He-Ying Hu, Ya-Ru Zhang, Qiaolifan Aerqin, Ya-Nan Ou, Zuo-Teng Wang, Wei Cheng, Jian-Feng Feng, Lan Tan & Jin-Tai Yu. (2022) Association between multimorbidity status and incident dementia: a prospective cohort study of 245,483 participants. Translational Psychiatry 12:1.
Crossref
A R M Saifuddin Ekram, Robyn L. Woods, Joanne Ryan, Sara E. Espinoza, Julia F.M. Gilmartin-Thomas, Raj C. Shah, Raaj Mehta, Bharati Kochar, Judy A. Lowthian, Jessica Lockery, Suzanne Orchard, Mark Nelson, Michelle A. Fravel, Danny Liew & Michael E. Ernst. (2022) The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals. Archives of Gerontology and Geriatrics 101, pages 104694.
Crossref
Ho Jin Cho, Jungmi Chae, Sang-Heon Yoon & Dong-Sook Kim. (2022) Aging and the Prevalence of Polypharmacy and Hyper-Polypharmacy Among Older Adults in South Korea: A National Retrospective Study During 2010–2019. Frontiers in Pharmacology 13.
Crossref
Junya Ebina, Satoru Ebihara & Osamu Kano. (2022) Similarities, differences and overlaps between frailty and Parkinson's disease. Geriatrics & Gerontology International 22:4, pages 259-270.
Crossref
Louise M. LavrencicKim DelbaereGerald A. BroeGail DaylightBrian DraperRobert G. CummingGail GarveyWendy AllanThi Yen HillDanielle LasschuitPeter R. SchofieldKylie Radford. (2022) Dementia Incidence, APOE Genotype, and Risk Factors for Cognitive Decline in Aboriginal Australians . Neurology 98:11.
Crossref
Muhamad S. Aljeaidi & Edwin CK. Tan. (2022) The association between polypharmacy and cognitive ability in older adults: A national cohort study. Research in Social and Administrative Pharmacy 18:3, pages 2505-2509.
Crossref
Akshaya Srikanth Bhagavathula, Wubshet Tesfaye, Kota Vidyasagar & Daniela Fialova. (2022) Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis. Gerontology 68:10, pages 1081-1090.
Crossref
Danielle Newby. 2020. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy 1 15 .
Niklas Frahm, Michael Hecker & Uwe Klaus Zettl. (2021) Polypharmacy in Chronic Neurological Diseases: Multiple Sclerosis, Dementia and Parkinson’s Disease. Current Pharmaceutical Design 27:38, pages 4008-4016.
Crossref
Daniel A. Harris & Andrea Iaboni. (2021) Over the top: psychotropic polypharmacy in long-term care. International Psychogeriatrics 33:10, pages 1015-1017.
Crossref
Dylan J. Jester, Victor Molinari, Janice C. Zgibor & Ladislav Volicer. (2021) Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis. International Psychogeriatrics 33:10, pages 1083-1098.
Crossref
Sarah L. Hillebrand, Esmee M. Reijnierse, Carel G.M. Meskers & Andrea B. Maier. (2021) Orthostatic hypotension assessed by active standing is associated with worse cognition in geriatric rehabilitation inpatients, RESORT. Archives of Gerontology and Geriatrics 96, pages 104482.
Crossref
Kazuhisa Watanabe, Hiroyuki Umegaki, Taiki Sugimoto, Chisato Fujisawa, Hitoshi Komiya, Masaaki Nagae, Yosuke Yamada, Masafumi Kuzuya & Takashi Sakurai. (2021) Associations Between Polypharmacy and Gait Speed According to Cognitive Impairment Status: Cross-Sectional Study in a Japanese Memory Clinic. Journal of Alzheimer's Disease 82:3, pages 1115-1122.
Crossref
Sirinoot Palapinyo, Janthima Methaneethorn & Nattawut Leelakanok. (2021) Association between polypharmacy and depression: a systematic review and meta‐analysis. Journal of Pharmacy Practice and Research 51:4, pages 280-299.
Crossref
Amal A. Ismail, Nada S. Alghasham, Rawan E. Alsukhaiber & Fatimah M. Alnowiasser. (2021) Dementia screening of geriatric patients by implementing an informant-based Alzheimer's disease eight-item tool in KSA. Journal of Taibah University Medical Sciences 16:2, pages 191-197.
Crossref
Jinghuan Gan, Shuai Liu, Zhichao Chen, Xiao-Dan Wang & Yong Ji. (2021) Effect of Multiple Medicines on Dementia Initial Treatment: Experience and Thinking. American Journal of Alzheimer's Disease & Other Dementias® 36, pages 153331752110531.
Crossref
Junya Nakamura, Kazufumi Kitagaki, Yuya Ueda, Eri Nishio, Takeshi Shibatsuji, Yasuyuki Uchihashi, Ryohei Adachi & Rei Ono. (2020) Impact of polypharmacy on oral health status in elderly patients admitted to the recovery and rehabilitation ward. Geriatrics & Gerontology International 21:1, pages 66-70.
Crossref
Shanna C. Trenaman, Susan K. Bowles, Susan A. Kirkland & Melissa K. Andrew. (2021) Potentially Inappropriate Drug Duplication in a Cohort of Older Adults with Dementia. Current Therapeutic Research 95, pages 100644.
Crossref
Nicole McDerby, Sam Kosari, Kasia Bail, Alison Shield, Greg Peterson & Mark Naunton. (2020) Pharmacist‐led medication reviews in aged care residents with dementia: A systematic review. Australasian Journal on Ageing 39:4.
Crossref
Juliana Dias de Lima, Ivan Abdalla Teixeira, Felipe de Oliveira Silva & Andrea Camaz Deslandes. (2020) The comorbidity conditions and polypharmacy in elderly patients with mental illness in a middle income country: a cross-sectional study⋆. IBRO Reports 9, pages 96-101.
Crossref
Kim E. Innes & Usha Sambamoorthi. (2020) The Potential Contribution of Chronic Pain and Common Chronic Pain Conditions to Subsequent Cognitive Decline, New Onset Cognitive Impairment, and Incident Dementia: A Systematic Review and Conceptual Model for Future Research. Journal of Alzheimer's Disease 78:3, pages 1177-1195.
Crossref
Sirasa Ruangritchankul, Nancye M. Peel, Leila Shafiee Hanjani & Leonard C. Gray. (2020) Drug related problems in older adults living with dementia. PLOS ONE 15:7, pages e0236830.
Crossref
Marcela Forgerini, Maria Teresa Herdeiro, José Carlos Fernandes Galduróz & Patrícia de Carvalho Mastroianni. (2020) Risk factors associated with drug therapy among elderly people with Alzheimer’s disease: a cross-sectional study. Sao Paulo Medical Journal 138:3, pages 216-218.
Crossref
Labib AL-Musawe, Ana Paula Martins, Joao Filipe Raposo & Carla Torre. (2019) The association between polypharmacy and adverse health consequences in elderly type 2 diabetes mellitus patients; a systematic review and meta-analysis. Diabetes Research and Clinical Practice 155, pages 107804.
Crossref
Min Li, Zheng Luo, Sisi Yu & Zhenyu Tang. (2019) Proton pump inhibitor use and risk of dementia. Medicine 98:7, pages e14422.
Crossref
Woody Chang, Marcia Homer & Michelle Rossi. (2018) Use of Clinical Video Telehealth as a Tool for Optimizing Medications for Rural Older Veterans with Dementia. Geriatrics 3:3, pages 44.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.